Elanco Announces Agreement to Acquire ChemGen Corp.
US - Elanco, the animal health division of Eli Lilly and Company, yesterday announced that Lilly has signed an agreement to acquire ChemGen, Corp., a privately held bioscience company specializing in the development and commercialization of innovative feed enzyme products that improve the efficiency of poultry, egg, and meat production.